Nengbin Wan
YOU?
Author Swipe
View article: Laparoscopically harvested omental flap for immediate breast reconstruction: a retrospective single-center study of 300 cases
Laparoscopically harvested omental flap for immediate breast reconstruction: a retrospective single-center study of 300 cases Open
Background The laparoscopically harvested omental flap (LHOF) has been used in partial or total breast reconstruction, but most studies on LHOF were case reports or small case series. However, the clinical feasibility and oncological safet…
View article: A global bibliometric and visualized analysis of the status and trends of bone metastasis in breast cancer research from 2002 to 2021
A global bibliometric and visualized analysis of the status and trends of bone metastasis in breast cancer research from 2002 to 2021 Open
View article: Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study
Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study Open
Our study confirmed the benefit of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy on pCR with a tolerable safety profile in routine clinical practice in Chinese patients with HER2-positive BC. HR-negativity and Ki…
View article: [Application of pedicled omentum flap in breast reconstruction of breast cancer patients].
[Application of pedicled omentum flap in breast reconstruction of breast cancer patients]. Open
The pedicled omentum flap can be harvested safely and reliable, which is the one of ideal option for breast reconstruction in breast cancer patients.
View article: miRNA‐192‐5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A
miRNA‐192‐5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A Open
The administration of doxorubicin (DOX) is one of the first‐line treatments of breast cancer. However, acquisition of resistance remains the major obstacle restricting the clinical application of DOX. MicroRNAs (miRNAs) are small, noncodin…